Lung Lesions of TB Variable, Independent Whether Infection is Active or Latent

The lung lesions in an individual infected with tuberculosis (TB) are surprisingly variable and independent of each other, despite whether the patient has clinically active or latent disease, according to a new animal study led by researchers at the University of Pittsburgh School of Medicine. The findings, published online today in Nature Medicine, could point the way to new vaccines to prevent the hard-to-treat infection.
 
More than 30 percent of the world's population is infected with Mycobacterium tuberculosis, the bacterium that causes TB, yet only 5 to 10 percent of those infected develop active, contagious disease with symptoms of coughing, chest pain, night sweats and weight loss. Most have asymptomatic, or "latent," infections that are not contagious, but could become active years later.
 
When the lungs become infected with M. tuberculosis, the body's immune system walls off the bacteria into lesions called granulomas, explains co-senior investigator JoAnne Flynn, PhD, professor of microbiology and molecular genetics at the Pitt School of Medicine.
 
"It's long been thought that the patient with a weakened immune system or some other immune vulnerability was more likely to develop active disease," Flynn says. "But to our surprise, our study showed that every infected individual has a collection of granulomas, some containing live bacteria and some that are sterile because the immune system has killed all the bacteria. So in this sense, there's no such thing as a latent or active granuloma."
 
For the study, the research team infected monkeys with TB and then carefully tracked the granulomas that developed in the lungs. They determined that each granuloma starts with only one bacterium, and that bacterial replication continued for about four weeks before the body counters with an adaptive immune response to kill off the invaders.
 
"This response was sufficient to kill all the bacteria and sterilize some granulomas, but bacteria persisted in others and spread to create new granulomas," Flynn says. "You need only one granuloma to 'go bad' in order to get active TB."
 
Even when an animal had a severe, active infection, some of their granulomas were sterile, indicating the immune system was capable of killing bacteria, the researchers found.
 
"We don't know yet why the immune response produced different results in different lesions," Flynn says. "When we develop a deeper understanding of why the immune response produced different results in different lesions, we will be closer to harnessing the right mechanisms to develop effective vaccines to prevent TB."

The project was funded by the Bill & Melinda Gates Foundation; the Otis Childs Trust of the Children's Hospital of Pittsburgh Foundation; National Institutes of Health (NIH) grants HL106804, AI094745, DP2 0D001378 and AI076217; the NIH's National Institute of Allergy and Infectious Diseases grant DAIT BAA-05-10, the Howard Hughes Medical Institute, the Physician Scientist Early Career Award, the Harvard Merit Fellowship, the Burroughs Wellcome Foundation Investigator in the Pathogenesis of Infectious Diseases Fellowship, the Robert A. Welch Foundation and the Melvin J. and Geraldine L. Glimcher Associate Professorship.

Source: University of Pittsburgh School of Medicine